Discover how to introduce the rivaroxaban molecule into your market!
Rivaroxaban was one of the most sold pharmaceutical substances in 2020. It is a part of RC REDOL’s portfolio, available to be introduced in your market, since its patent will expire in 2024. This oral anticoagulant is recommended for the treatment of coronary arteries and peripheral arteries diseases and it is used both as a …
Read more “Discover how to introduce the rivaroxaban molecule into your market!”
